Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35721 | 1.00 | TTR (0.32) | TTR | |
| SCHEMBL35617 | 1.00 | TTR (0.32) | TTR | |
| SCHEMBL8592740 | 1.00 | TTR (0.32) | TTR | |
| SCHEMBL759662 | 0.80 | — | — | |
| SCHEMBL25345972 | 0.73 | — | — | |
| SCHEMBL3856080 | 0.70 | — | — | |
| SCHEMBL8592598 | 0.70 | — | — | |
| SCHEMBL5071979 | 0.70 | — | — | |
| SCHEMBL2411810 | 0.62 | — | — | |
| SCHEMBL12062168 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4211141-A1 | SILACROWN ETHERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THERAPEUTIC APPLICATIONS THEREOF | Arkles, Barry, C. (US) | 2023-07-19 | — | — | EP | claimed |
| WO-2022055745-A1 | SILACROWN ETHERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THERAPEUTIC APPLICATIONS THEREOF | ARKLES BARRY C (US) | 2022-03-17 | — | — | WO | claimed |
| US-4906317-A | Instant adhesive composition and bonding method employing same | LOCTITE CORPORATION (US) | 1990-03-06 | — | — | US | claimed |
| EP-0142327-B1 | INSTANT ADHESIVE COMPOSITION | LOCTITE CORPORATION (US) | 1987-05-13 | — | — | EP | claimed |
| US-12606719-B2 | Methods and compositions comprising biodegradable cyanoacrylates | FEMASYS INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-20260103623-A1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HENKEL AG & CO KGAA (DE) | 2026-04-16 | — | — | US | disclosed |
| EP-4061865-B1 | TWO COMPONENT (2K) CURABLE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-12582546-B2 | Methods and devices for controlled delivery | FEMASYS INC. (US) | 2026-03-24 | — | — | US | disclosed |
| EP-3867323-B1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HENKEL AG & CO KGAA (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-20260071097-A1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HENKEL AG & CO KGAA (DE) | 2026-03-12 | — | — | US | disclosed |
| US-20260062590-A1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | FEMASYS INC (US) | 2026-03-05 | — | — | US | disclosed |
| EP-3837327-B1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HENKEL AG & CO KGAA (DE) | 2025-11-12 | — | — | EP | disclosed |
| US-20040131827-A1 | Toughened cyanoacrylate compositions | LOCTITE (R&D) LIMITED | 2004-07-08 | — | — | US | disclosed |
| US-6323275-B2 | HAVING A LOWERED ADHESION TO THE SKIN | TOAGOSEI CO., LTD. (JP) | 2001-11-27 | — | — | US | disclosed |
| US-20010004655-A1 | CYANOACRYLATE ADHESIVE COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2001-06-21 | — | — | US | disclosed |
| WO-1998054092-A1 | PREPARATION OF ZEOLITE-BOUND FAU STRUCTURE TYPE ZEOLITE AND USE THEREOF | EXXON CHEMICAL PATENTS INC. (US) | 1998-12-03 | — | — | WO | disclosed |
| US-5393511-A | Faujasite zeolites with hexagonal, cubic or mixed structure | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1995-02-28 | — | — | US | disclosed |
| US-5098686-A | A porous zeolite as catalysts | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1992-03-24 | — | — | US | disclosed |
| US-4906317-A | Instant adhesive composition and bonding method employing same | LOCTITE CORPORATION (US) | 1990-03-06 | — | — | US | disclosed |
| US-4699991-A | DISPLACEMENT CATALYSTS | PETRARCH SYSTEMS INC. (US) | 1987-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071097-A1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | AHCYL1, CRKL, MMAB | TTR 1125/4885 |
| US-20260062590-A1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | PGF, ACR, FGB | TTR 2318/4885 |
| US-12582546-B2 | Methods and devices for controlled delivery | PGF, GNRHR, LHCGR | TTR 4071/4885 |
| US-12606719-B2 | Methods and compositions comprising biodegradable cyanoacrylates | MKI67, ACR, PGF | TTR 3244/4885 |
| US-20260103623-A1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HSPA4L, HACL2, CRKL | TTR 2256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.